Member Info for Livedataaccount

I wonder what alan would do right now

Golf nut great post who to believe avacta or thornogson an ex hospital porter no offense thornogson

After the recent update I have decided to stop asking for updates thats it no more as they are simply miles away from what i expect i was expecting perhaps naively that these results would be towards the end of the sgc phase 1b and not what sounded early results with a long road ahead in 1b which leads me to thing that tnbc are sts remember that are further away i do hope early results in 6103 are good but i shall stop asking

So when is it starting please yesterday it was q1 2026 and today is ready to go which is it please thank you

I'm getting tired of the science now it's been 4 years

Its an estimated guess as the broker ZEUZ is at the top of the bid ie. front of the queue they have been there all this morning too so my guess is accumalating or stabilising the share price all conjecture but certainly at the top of the bid

Brluenq perhaps it's the fact that all communications are heavily stacked on the science with commercials a side note or not talked about

Do others feel a sense of frustration towards avacta at the moment especially after yesterday can't quite put my finger n the reason amd I fully back the CEO but still feel a slight annoyance

Interesting Zeus capital have been on the bid happy to buy avatas shares for hours bear in mind richard hughes avactas non exec director pretty much owns zeus i believe interesting to see his broker in the position right now

Christina Coughlin

@coughlin582

Our trip to Glasgow to view the manufacturing of AVA6103 was a huge success. Sharing our new data and their new data are key signs of a great collaboration. This joint team is full of top notch folks and we are thrilled to move ahead with them in the program.

#LetsDoThis

Avacta meets Novartis : Single and dual warhheads very interesting however feel slightly for whoever has made that oversight

Download the pdf from investor meets company and check the title. Its called avacta meets Novartis

Avacta meets Novartis?

Timster cc was speaking and made it clear sgc isnt going into phase 2 next week and mentioned further to go in terms of data and this caused a sell off

Our CEO

@coughlin582

and COO Karen Harrison were thrilled to visit our manufacturing partner Curia this week to witness the some of the last steps in the manufacturing process for our next program, FAP-Exd (AVA6103).

Looking forward to the next stage of development! #AVCT

Https://x.com/i/status/2001247875196707001

Manufacturing the magic for 6103

Took you are better than this give it a rest it was phase 1b sgc data I can only imagine you are quite bored

Correct timster as much as all want more news this was about sgc 1b as stated and it was very good news well done avacta

The headline says it all

Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers

Can we please have a paragraph on the Phase 1b tnbc trial in tomorrows rns doesnt have to be long just how many patients have been dosed pfs rate and any responses thank you